4-hydroxycinnamoyl(feroyl)methane, curcumin II, demethoxy-curcumin, demethoxycurcumin, monodemethoxycurcumin
Name | Demethoxycurcumin | ||
PubChem CID | 5469424 | ||
Molecular Weight | 338.4g/mol | ||
Synonyms |
4-hydroxycinnamoyl(feroyl)methane, curcumin II, demethoxy-curcumin, demethoxycurcumin, monodemethoxycurcumin |
||
Formula | C₂₀H₁₈O₅ | ||
SMILES | COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O | ||
InChI | 1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+ | ||
InChIKey | HJTVQHVGMGKONQ-LUZURFALSA-N | ||
CAS Number | 22608-11-3 | ||
ChEMBL ID | CHEMBL105360 | ||
ChEBI ID | CHEBI:65737 | ||
Herb ID | HBIN023227 | ||
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | BiBa | ||
Use Part | Near Ripe Or Ripe Fruit Spike | ||
Habitat | YunNan, GuangDong | ||
Flavor | Pungent | ||
Meridian Tropism | Stomach, Large intestine | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Piperales
-->Family: Piperaceae
-->Genus: Piper
-->Species: Piper longum
|
Chineses Pinyin | JiangHuang | ||
Use Part | Tuberoid | ||
Habitat | SiChuan, FuJian, GuangDong, ZheJiang, JiangXi | ||
Flavor | Pungent; Bitter | ||
Meridian Tropism | Spleen; Liver | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Zingiberales
-->Family: Zingiberaceae
-->Genus: Curcuma
-->Species: Curcuma longa
|
Pair Name | Demethoxycurcumin, Cisplatin | |||
Partner Name | Cisplatin | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
In Vivo Model | For a xenograft model, A549/DDP cells were injected into the inguinal mammary fat pad of Balb/c congenic athymic nude mice. | |||
Result | The findings from the present study suggested that DMC in combination with DDP may be considered as a novel combination regimen for restoring DDP sensitivity in DDP-resistant NSCLC cells. |
Pair Name | Demethoxycurcumin, AT101 | |||
Partner Name | AT101 | |||
Disease Info | [ICD-11: 2A00] | Glioblastoma multiforme | Investigative | |
Gene Regulation | Up-regulation | Phosphorylation | AKT1 | hsa207 |
In Vitro Model | PC-1 [Human pancreatic carcinoma] | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_S969 |
PC-2 [Human pancreatic carcinoma Germany] | Pancreatic carcinoma | Homo sapiens (Human) | CVCL_C1YF | |
PC-3 | Prostate carcinoma | Homo sapiens (Human) | CVCL_0035 | |
Result | Combined treatment with different drugs might be an option to efficiently overcome chemoresistance of GBM cells in a long-term treatment strategy. |
No. | Title | Href |
---|---|---|
1 | Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway. Oncol Lett. 2020 Nov;20(5):209. doi: 10.3892/ol.2020.12072. | Click |
2 | Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. J Cancer Res Clin Oncol. 2020 Jan;146(1):117-126. doi: 10.1007/s00432-019-03107-7. | Click |